Jump to navigation
The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
The proportion of people affected by the leading cause of death for people living with HIV, tuberculosis, is on the rise in Europe.
The first trials enhancing orally-taken antiretroviral treatment with Solid Drug Nanoparticle technology have produced “incredibly promising” results.
Just over a year since launch, a new mobile app is helping Kenya track progress, plan and allocate resources for the HIV response, providing useful learning for other countries.
To mark International Women’s Day, we hear from Emily, a peer educator from Malawi who dedicates her life ensuring other women have access to the information and support they need to seek testing and live positively.
To mark International Women’s Day, we hear from Justine, a young mother living with HIV in Cameroon who has taken her diagnosis in her stride.
The first ever study evaluating the decentralising of HIV care through antiretroviral treatment (ART) distribution centres shows low rates of patient loss in the city.
People with disabilities in developing countries are at high risk of HIV infection with HIV prevalence nearly double that than among those without disabilities.
‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.
Drug trial results for new integrase inhibitor show promising viral suppression rates.
Mixed-status couples using PrEP could benefit from HIV self-testing as a way to quickly diagnose any new infections and reduce frequency of clinic visits.